Reactions of 2,2-dimethylaziridine-type alkylating agents in biological systems II: comparative pharmacokinetics in dogs.
暂无分享,去创建一个
[1] D. Lalka,et al. Reactions of 2,2-dimethylaziridine-type alkylating agents in biological systems. I. Colorimetric estimation and stability in physiological media. , 1973, Journal of pharmaceutical sciences.
[2] T. Suzuki,et al. Pharmacokinetic analysis of blood level data interpreted by a two-compartment model. , 1973, Chemical & pharmaceutical bulletin.
[3] A. Munson,et al. Studies on the chemistry, antitumor activity, and pharmacology of ethyl Di‐(2,2 ‐dimethyl)ethylenamido phosphate (AB‐163) , 1969, Journal of surgical oncology.
[4] D. Triggle,et al. A STUDY OF COMPARATIVE CHEMICAL AND BIOLOGICAL ACTIVITIES OF ALKYLATING AGENTS. , 1965, Journal of medicinal chemistry.
[5] J. Webster,et al. Combined use of AB‐132 (Meturedepa, Turloc) and X irradiation in the management of advanced bronchogenic carcinoma , 1964, Cancer.
[6] W. Regelson,et al. THE EFFECT OF RADIATION ON SPLENOMEGALY INDUCED BY THE FRIEND LEUKEMIA VIRUS AND ITS MODIFICATION BY ETHY-N-BIS(2,2-DIMETHYL-ETHYLAMIDINOPHOSPHORO)-CARBAMATE (AB-132), ACTINOMYCIN D, AND AET. , 1964, Radiation research.
[7] L. A. Woods,et al. The Comparative Physiological Disposition of ThioTEPA and TEPA in the Dog , 1960 .
[8] L. A. Woods,et al. The Fluorometric Estimation of Mechlorethamine (Mustargen) and Its Biological Disposition in the Dog , 1960 .
[9] P. K. Smith,et al. Preliminary studies on the distribution and fate of TEM, TEPA, and myleran in the human. , 1959, Cancer research.